The GRAVITI Study is comparing the safety and efficacy of an investigational medication compared with placebo in adults with moderately to severely active Crohn's disease.
See If You Are EligibleClinical research is not only how we get new treatments approved, but it is also used to explore how treatments are delivered. Although some of the approved treatments for Crohn's disease are delivered intravenously, or through a vein, the GRAVITI Study will explore whether an investigational medication delivered in a less invasive way-subcutaneously, or under the skin-is safe and effective.
You may be able to take part in the GRAVITI Study if you:
Additional eligibility criteria will be assessed by the trial doctor or staff.
SEE IF YOU ARE ELIGIBLE